Demirkol, S. Et Al. 2017. A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer. JOURNAL OF CANCER , vol.8, no.7 , 1113-1122.

Demirkol, S., Gomceli, I., Isbilen, M., Dayanc, B. E., Tez, M., Bostanci, E. B., ... Turhan, N.(2017). A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer. JOURNAL OF CANCER , vol.8, no.7, 1113-1122.

Demirkol, Secil Et Al. "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer," JOURNAL OF CANCER , vol.8, no.7, 1113-1122, 2017

Demirkol, Secil Et Al. "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer." JOURNAL OF CANCER , vol.8, no.7, pp.1113-1122, 2017

Demirkol, S. Et Al. (2017) . "A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer." JOURNAL OF CANCER , vol.8, no.7, pp.1113-1122.

@article{article, author={Secil Demirkol Et Al. }, title={A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer}, journal={JOURNAL OF CANCER}, year=2017, pages={1113-1122} }